Log In
BCIQ
Print this Print this
 

TD-1473

  Manage Alerts
Collapse Summary General Information
Company Theravance Biopharma Inc.
DescriptionIntestinally restricted pan-Janus kinase (JAK) inhibitor
Molecular Target Janus kinase (JAK)
Mechanism of ActionJanus kinase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today